The Clinical Significance of Preoperative 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography for Predicting Distant Recurrence in Thymoma

被引:0
|
作者
Niikawa, H. [1 ,2 ]
Watanabe, T. [1 ,2 ]
Notsuda, H. [1 ,2 ]
Shibata, S. [1 ,2 ]
Onodera, K. [1 ,2 ]
Watanabe, Y. [1 ,2 ]
Hirama, T. [1 ,2 ]
Suzuki, T. [1 ,2 ]
Oishi, H. [1 ,2 ]
Noda, M. [1 ,2 ]
Takanami, K. [3 ]
Takase, K. [3 ]
Okada, Y. [1 ,2 ]
机构
[1] Tohoku Univ, Inst Dev Aging & Canc, Dept Thorac Surg, 4-1 Seiryomachi, Sendai, Miyagi 9808574, Japan
[2] Tohoku Univ Hosp, Dept Thorac Surg, Sendai, Miyagi, Japan
[3] Tohoku Univ Hosp, Dept Diagnost Radiol, Sendai, Miyagi, Japan
关键词
Masaoka stage; recurrence pattern; SUVmax; thymic epithelial tumour; tumour size; THYMIC EPITHELIAL TUMORS; HEALTH-ORGANIZATION HISTOLOGY; STAGE-II; UTILITY; SIZE; CLASSIFICATION; GRADE; RATIO;
D O I
10.1016/j.clon.2022.10.006
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Aims: Thymomas sometimes require treatment for various recurrence patterns, despite their relatively good survival rates after resection. We focused on their maximum standardised uptake value (SUVmax) on preoperative 18F-fluorodeoxyglucose positron emission tomography as a tumour recurrence predictor in completely resected thymomas. Those with a high SUVmax might be at an increased recurrence risk, irrespective of tumour size. We categorised cases into axes (tumour size and SUVmax) and determined whether cluster analysis predicts recurrence patterns and freedom from recurrence (FFR). Materials and methods: Of the 115 patients who underwent primary surgery for thymoma between 2005 and 2018, 66 were evaluated. According to the Masaoka stage and World Health Organization (WHO) histological type, all histological diagnoses were obtained after resection. All recurrences were diagnosed using computed tomography and categorised into three patterns: distant, local and regional recurrences. A multiple regression analysis was carried out to identify predictors for each recurrence pattern. Cluster analysis was carried out based on tumour size and SUVmax. The FFR rate was evaluated. Results: All patients with preoperative SUVmax <3.4 were free from recurrence regardless of Masaoka stage, WHO histological classification and tumour size. Multiple regression analysis revealed that the SUVmax was the only significant predictor for distant recurrence. All cases were divided into three clusters. Cluster 3, with average tumour size and a high SUVmax, showed a higher risk of distant recurrence rate (60%) and a significantly lower FFR rate (P = 0.003). Conclusions: The preoperative positron emission tomography/computed tomography SUVmax could be a useful thymoma recurrence predictor, especially for distant recurrences. In addition, cluster analysis revealed that cases with average tumour sizes and extremely high SUVmax were identified to have a higher recurrence risk and a significantly lower FFR rate than those in other clusters. Even after complete resection, such cases should be closely followed-up and screened for distant recurrence. (c) 2022 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:E153 / E162
页数:10
相关论文
共 50 条
  • [41] Impact of metabolic indices of 18F-fluorodeoxyglucose positron emission tomography/computed tomography on post transplantation recurrence of hepatocellular carcinoma
    Astrid Bauschke
    Annelore Altendorf-Hofmann
    Lukas Brückner
    Robert Drescher
    Martin Freesmeyer
    Utz Settmacher
    Journal of Cancer Research and Clinical Oncology, 2023, 149 : 1401 - 1410
  • [42] Clinical impact of 18F-fluorodeoxyglucose positron emission tomography/computed tomography in the evaluation of small cell carcinoma of the prostate
    Sahiner, I.
    Akkas, B. E.
    Vural, G. Ucmak
    REVISTA ESPANOLA DE MEDICINA NUCLEAR E IMAGEN MOLECULAR, 2013, 32 (03): : 193 - 195
  • [43] Evaluation of Wegener's granulomatosis using 18F-fluorodeoxyglucose positron emission tomography/computed tomography
    Ito, Kimiteru
    Minamimoto, Ryogo
    Yamashita, Hiroyuki
    Yoshida, Setsuko
    Morooka, Miyako
    Okasaki, Momoko
    Mimori, Akio
    Kubota, Kazuo
    ANNALS OF NUCLEAR MEDICINE, 2013, 27 (03) : 209 - 216
  • [44] Detection of Giant Cell Aortitis Using 18F-Fluorodeoxyglucose Positron Emission Tomography Computed Tomography
    Bogaard, K.
    Schrama, J. G.
    Voogel, A. J.
    Zwijnenburg, A.
    Ezechiels, J. P.
    CIRCULATION, 2010, 122 (05) : E411 - E412
  • [45] Diffuse oesophageal candidiasis identified on 18F-fluorodeoxyglucose positron emission tomography/computed tomography scan
    Shephard, Christopher James
    Wang, William Jiaen
    Baran, Bulent
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2024, 39 : 364 - 365
  • [46] Imaging spectrum and pitfalls of 18F-fluorodeoxyglucose positron emission tomography/computed tomography in patients with tuberculosis
    Kimiteru Ito
    Miyako Morooka
    Ryogo Minamimoto
    Yoko Miyata
    Momoko Okasaki
    Kazuo Kubota
    Japanese Journal of Radiology, 2013, 31 : 511 - 520
  • [47] Automated Measurement of Effective Radiation Dose by 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography
    Eom, Yujin
    Park, Yong-Jin
    Lee, Sumin
    Lee, Su-Jin
    An, Young-Sil
    Park, Bok-Nam
    Yoon, Joon-Kee
    TOMOGRAPHY, 2024, 10 (12)
  • [48] The role of 18F-fluorodeoxyglucose positron emission tomography/computed tomography in the primary staging of rectal cancer
    Salih Erpulat Ozis
    Cigdem Soydal
    Cihangir Akyol
    Nalan Can
    Ozlem Nuriye Kucuk
    Cemil Yagcı
    Ayhan Bulent Erkek
    Mehmet Ayhan Kuzu
    World Journal of Surgical Oncology, 12
  • [49] Unexpected Benefit of the Positron Emission Tomography/Computed Tomography Using 18F-Fluorodeoxyglucose: Report of a Case
    Cemil Caliskan
    Can Karaca
    Mustafa Ozsoy
    Erhan Akgun
    Mustafa A. Korkut
    Indian Journal of Surgery, 2016, 78 : 348 - 350
  • [50] Metastatic thymic carcinoma on restaging 18F-fluorodeoxyglucose positron emission tomography-computed tomography
    Hoe Khoo, Alex Cheen
    Ang, Soo Fan
    INDIAN JOURNAL OF NUCLEAR MEDICINE, 2020, 35 (04): : 364 - 366